[HTML][HTML] The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder

SV Faraone, T Banaschewski, D Coghill… - … & biobehavioral reviews, 2021 - Elsevier
Background Misconceptions about ADHD stigmatize affected people, reduce credibility of
providers, and prevent/delay treatment. To challenge misconceptions, we curated findings …

[HTML][HTML] Evidence-based pharmacological treatment options for ADHD in children and adolescents

K Mechler, T Banaschewski, S Hohmann… - Pharmacology & …, 2022 - Elsevier
Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder
characterized by inattention, hyperactivity, and impulsivity, causing functional impairment. Its …

Updated European Consensus Statement on diagnosis and treatment of adult ADHD

JJS Kooij, D Bijlenga, L Salerno, R Jaeschke… - European …, 2019 - cambridge.org
Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common
psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD …

[HTML][HTML] Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan

B Franke, G Michelini, P Asherson… - European …, 2018 - Elsevier
Attention-deficit/hyperactivity disorder (ADHD) is highly heritable and the most common
neurodevelopmental disorder in childhood. In recent decades, it has been appreciated that …

A literature review and meta-analysis on the effects of ADHD medications on functional outcomes

H Boland, M DiSalvo, R Fried, KY Woodworth… - Journal of psychiatric …, 2020 - Elsevier
Objective To conduct a systematic review and meta-analysis of literature from large
databases and registries to assess the effects of ADHD medication on associated functional …

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)

OJ Storebø, MRO Storm, JP Ribeiro… - Cochrane Database …, 2023 - cochranelibrary.com
Background Attention deficit hyperactivity disorder (ADHD) is one of the most commonly
diagnosed and treated psychiatric disorders in childhood. Typically, children and …

Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents–assessment of adverse events in non‐randomised studies

OJ Storebø, N Pedersen, E Ramstad… - Cochrane Database …, 2018 - cochranelibrary.com
Background Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …

[HTML][HTML] Attention-deficit/hyperactivity disorder: a current overview

T Banaschewski, K Becker, M Döpfner… - Deutsches Ärzteblatt …, 2017 - ncbi.nlm.nih.gov
Background Attention-deficit/hyperactivity disorder (ADHD) is a common, early-onset,
persistent developmental disorder of childhood and adolescence, with a prevalence of …

Adult attention-deficit hyperactivity disorder: key conceptual issues

P Asherson, J Buitelaar, SV Faraone… - The Lancet …, 2016 - thelancet.com
For many years, attention-deficit hyperactivity disorder (ADHD) was thought to be a
childhood-onset disorder that has a limited effect on adult psychopathology. However, the …

Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic …

KKC Man, A Häge, T Banaschewski, SK Inglis… - The Lancet …, 2023 - thelancet.com
Background Methylphenidate is the most frequently prescribed medication for the treatment
of ADHD in children and adolescents in many countries. Although many randomised …